Dealmakers newsletter: August 2008
Welcome to August's edition of the Dealmakers newsletter from CurrentPartnering.
Sponsored by: Intralinks | Verticali | EuroPLX | DMS Data Systems
If not already signed up to receive our newsletters, do so here.
In this issue:
- Editor's corner
- Networks launched
- New partnering reports
- In the news - July/August 2008
- New best practice articles
- Forthcoming events
- Scorecards - newly updated with latest deals
- People on the move
- Partnering resources: Software tools
- Glossary of partnering terms
The August issue of Dealmakers is sponsored by:
BioBusiness Network 2008
For more information, please visit the conference website
EDITOR'S CORNER
July saw the successful launch of our NETWORKS section - providing dealmakers with access to the CurrentPartnering Business Development Network at LinkedIn - Networks
Roche led the way in dealmaking in July numerous M&A and partnering announcements:
- MitoScience and Roche collaborate to investigate mitochondrial toxicity
- Simulations Plus and Roche sign multi-year collaboration
- Roche to buy ARIUS Research
- Roche acquires Mirus Bio Corporation
- Roche offers to buy out Genentech for $43.7 billion
- Scil Proteins in manufacturing deal for Reteplase with Roche
- Roche signs cancer alliance with BioInvent and ThromboGenics
We have been busy in our report publishing activities - our latest reports are now available
The report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies.
We have also made available Partnering Guides for each of the top 50 bigpharma companies for a modest $395 each. You can view a list of companies here.
The report adds to our growing portfolio of Agreements in Biopharma reports covering Clinical Stage Partnering Agreements in Biopharma, Co-promotion and Co-marketing, Merger and Acquisition, Manufacturing and Supply, Distribution, and Bigpharma.
You can also view the leading deals so far this year in our updated Scorecards.
Until next time - happy dealmaking!
- Steve Poile
NETWORKS LAUNCHED!
Networks facilitates the connecting of business developers in biopharma through the use of social networkings tools - including LinkedIn, Facebook, Twitter and GoogleMaps.
To join or participate in CurrentPartnering's Network tools, just click on the link below for further details Networks - join now!
NEW PARTNERING REPORTS
Partnering with Bigpharma
The report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies Partnering with Bigpharma
Individual Partnering Guides for each of the top 50 bigpharma companies - just $395 each
Pfizer - GlaxoSmithKline - Sanofi-Aventis - Novartis - AstraZeneca - Johnson & Johnson - Merck - Roche - Wyeth - Eli Lilly - Bristol-Myers Squibb - Mayer - Abbott - Amgen - Boehringer-Ingelheim - Schering-Plough - Takeda - Genentech - Teva - Novo Nordisk - Astellas - Daiichi Sankyo - Merck KGaA - Eisai - Otsuka - Servier - UCB - Baxter - Nycomed - Solvay - Gilead - Genzyme - Forest - Menarini - Allergan - Mitsubishi Tanabe - Chugai - Procter & Gamble - Ratiopharm - CSL - Barr - Alcon - Mundipharma - Shire - Biogen Idec - Stada - King - Lundbeck - Activis - Watson
Full list of top 50 companies covered
Clinical Stage Partnering Agreements in Biopharma
The Clinical Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the clinical stage partnering agreements entered into by the worlds leading biopharma companies Clinical Stage Partnering Agreements in Biopharma report.
Manufacturing and Supply Agreements in Biopharma
The Manufacturing and Supply Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the manufacturing and supply partnering agreements entered into by the worlds leading biopharma companies Manufacturing and Supply Agreements in Biopharma
Co-promotion & Co-marketing Agreements in Biopharma
The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma
Also:
- Distribution Agreements in Biopharma
- Bigpharma Partnering Agreements
- Merger and Acquisition Agreements in Biopharma
- Practical Guide to Finding Partners in Biopharma
IN THE NEWS
The latest partnering developments - July/August 2008:
In addition to the Roche deals at the top of the newsletter, here are some other notable M&A deals:
- Bristol-Myers Squibb offers to buy ImClone Systems for $60 a share
- Sanofi-Aventis to buy Acambis for $548 Million
- Sanofi-Aventis to acquire Symbion
- Teva Pharmaceutical to buy Barr Pharmaceuticals for $7.46 Billion
- Novartis to acquire Speedel Holding AG
- Eli Lilly to acquire SGX Pharmaceuticals
NEW BEST PRACTICE ARTICLES
IP Strategy, contracts and commercial relationship management
Notes from the presentation given by Duncan on Global IP Strategy 'read more now <http://www.currentpartnering.com/articles/1305>`_
IP Due Diligence Readiness
This article explains the importance of doing an IP due diligence upon oneself to reduce or eliminate risks associated with licensing, seeking capital for a start up or while planning for a trade sale of IP read more here
The Role of Competition in Bio-Technological Patenting and Innovation
This article examines the phenomenon of patenting as a strategy not so much to protect innovations but as a means of securing bargaining chips for access to others’ proprietary technologies read more
FORTHCOMING EVENTS
Here is our suggested partnering events for the fall of 2008.
BioPharm America 2008
Buckland, Atlanta, USA - September 9-10, 2008
BioPharm America is where biotech industry partnerships get started. Based on the same winning formula used in EBD Group’s distinguished European partnering conferences BIO-Europe and BIO-Europe Spring, BioPharm America is expected to become the premier stand-alone bio-pharma partnering event in North America BioPharm America 2008
BioBusiness Network 2008
Geneva, Switzerland - September 16-18, 2008
The Premier Global Bio-Partnering Event BioBusiness Network 2008
Pharmaceutical Strategic Alliances 2008
Marriott Financial Center, New York City, NY, USA - September 23-25, 2008
Meet the Most Important People in Dealmaking…The only conference that provides 100% case studies by CEOs and Senior Executives in the industry Pharmaceutical Strategic Alliances 2008
EuroPLX 37 Dresden
Dresden, Germany - October 6-7, 2008
Collaborative agreements in generics (incl. bio-generics and biosimilars), OTC drugs, and nutraceuticals EuroPLX 37 Dresden
4th Modern Drug Discovery & Development Summit
San Diego, CA, USA - October 15-17, 2008
The Modern Drug Discovery & Development Summit delivers a powerful package as the brightest minds in the pharmaceutical and biotechnological industries converge to share ideas and new developments in drug discovery - 4th Modern Drug Discovery & Development Summit
Therapeutic Area Partnerships 2008
Philadelphia, PA, USA - November 3-5, 2008
Windhover Information's 3rd Annual Therapeutic Area Partnerships is the industry's most targeted, efficient, and strategic-level partnering meeting for life science companies seeking partnerships in the top therapeutic areas: Oncology, Cardiovascular/Metabolic and Neuroscience Therapeutic Area Partnerships 2008
Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements
American Conference Institute's annual conference continues its tradition this year by bringing together key industry leaders and government representatives in order to discuss the critical issues impacting this ever changing landscape Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements
BioEurope 2008
Mannheim, Germany - November 17-19, 2008
The 14th annual BIO-Europe event is the world’s largest dedicated biotechnology partnering conference BioEurope 2008
SCORECARDS
Our scorecards have been updated with the latest deals to break into our most valuable deal rankings - the latest deal for 2008 to enter our partnering top 20 is GlaxoSmithKline and Mpex's $1,750m deal to give GSK access to Mpex's efflux pump inhibitor technology for use in treatment of gram-negative infections.
In addition, we have updated our top 25 bigpharma partnering activity scorecard for deals up to end July 2008.
- Partnering Top 20 - 2008
- Partnering Top 20 - 2007
- Partnering since 2000
- M&A Top 20 - 2008
- M&A Top 20 - 2007
- M&A since 2000
- Bigpharma Top 25 partnering - 2008
PEOPLE ON THE MOVE
The following people have been reported on the move during the weeks of July/August 2008:
Garry Menzel, Steven Hutchins, Mark Stejbach, Frances Heller, Michael Bailey, Joseph DePinto, Rick Soni, Jeffrey Frick to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
PARTNERING RESOURCES: SOFTWARE TOOLS
Numerous software tools exist to support the management and decision making in partnering - Software tools
GLOSSARY: UPDATED PARTNERING TERMS
The most recent addition is SPC or Supplementary Protection Certificate - a concession granted to pharma to extend protection under a patent more details
Full Glossary can be accessed here
Do you have specific glossary terms that you would like to see in our website? Give us your ideas here
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Scorecard Index
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Heads of agreement A pre-agreed document that outlines the key elements and structure of the planned deal.